JEN.DEJEN.DEXETRA
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR-25.9%
5Y CAGR-7.6%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
-25.9%/yr
vs +7.7%/yr prior
5Y CAGR
-7.6%/yr
Recent deceleration
Acceleration
-33.6pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20241.15-23.0%
20231.50+0.3%
20221.49-47.3%
20212.83+21.2%
20202.34+37.0%
20191.71+4.7%
20181.63-22.8%
20172.11+53.6%
20161.37+11.4%
20151.23-